James Samuel Shannon Horizon Therapeutics Public LTD CO (HZNP) insider trading activity

James Samuel Shannon is Director of Horizon Therapeutics Public Ltd Co. Currently has a direct ownership of 0 shares of HZNP, which is worth approximately $0. The most recent transaction as insider was on Oct 06, 2023, when has been sold 33,156 shares (Ordinary Shares) at a price of $116.5 per share, resulting in proceeds of $3,862,674. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

James Samuel Shannon Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 06 2023	SELL Sale (or disposition) back to the issuer	$3,862,674 $116.5 p/Share	33,156 Reduced 100.0%	0 Ordinary Shares
Sep 29 2023	BUY Exercise of conversion of derivative security	$144,451 $12.19 p/Share	11,850 Added 26.33%	33,156 Ordinary Shares
Apr 28 2023	SELL Payment of exercise price or tax liability	$208,869 $111.16 p/Share	1,879 Reduced 8.1%	21,306 Ordinary Shares
Apr 28 2023	BUY Exercise of conversion of derivative security	-	3,913 Added 14.44%	23,185 Ordinary Shares
Mar 01 2021	SELL Open market or private sale	$660,282 $91.3 p/Share	7,232 Reduced 100.0%	0 Ordinary Shares
Mar 01 2021	BUY Exercise of conversion of derivative security	$88,158 $12.19 p/Share	7,232 Added 50.0%	7,232 Ordinary Shares
Sep 13 2019	SELL Open market or private sale	$248,805 $26.19 p/Share	9,500 Reduced 100.0%	0 Ordinary Shares

Sep 13 2019	BUY Exercise of conversion of derivative security	$115,805 $12.19 p/Share	9,500 Added 50.0%	9,500 Ordinary Shares
Sep 12 2019	SELL Open market or private sale	$412,145 $26.59 p/Share	15,500 Reduced 100.0%	0 Ordinary Shares
Sep 12 2019	BUY Exercise of conversion of derivative security	$188,945 $12.19 p/Share	15,500 Added 50.0%	15,500 Ordinary Shares

Also insider at

MNKD

MANNKIND CORP Healthcare

XLO

Xilio Therapeutics, Inc. Healthcare

JSS